Iterum Therapeutics plc (ITRMF) Preferred Stock Liabilities (2017)

Iterum Therapeutics has reported Preferred Stock Liabilities for 1 years, with the latest figure at $57000.0 in Q4 2017.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $57000.0 in Q4 2017; TTM through Dec 2017 was $57000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $57000.0, up 90.0% from the prior year.
• Preferred Stock Liabilities was $57000.0 for Q4 2017 at Iterum Therapeutics.
• The five-year high for Preferred Stock Liabilities was $57000.0 in Q4 2017, with the low at $57000.0 in Q4 2017.